Dr Gay C Gilmore, MD in Crawford, NE - General Practice

Dr Gay C Gilmore, MD is a General Practice physician based in Crawford, Nebraska. Dr Gay C Gilmore is licensed to practice in Nebraska (license number 15292) and her current practice location is 211 E. Belmont Rd., Crawford, Nebraska. She can be reached at her office (for appointments etc.) via phone at (308) 665-1546.

NPI number for Dr Gay C Gilmore is 1518184555 and her current mailing address is Po Box 523, Crawford, Nebraska. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1518184555.

Contact Information

	Dr Gay C Gilmore, MD
	211 E. Belmont Rd., Crawford, NE 69339-0523
	(308) 665-1546
	Not Available

Physician's Profile

Full Name	Dr Gay C Gilmore
Gender	Female
Speciality	General Practice
Location	211 E. Belmont Rd., Crawford, Nebraska
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1518184555
Provider Enumeration Date: 04/19/2007
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr Gay C Gilmore such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1518184555	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	15292 (Nebraska)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Gay C Gilmore is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Gay C Gilmore, MD Po Box 523, Crawford, NE 69339-0523 Ph: (308) 665-1546	Dr Gay C Gilmore, MD 211 E. Belmont Rd., Crawford, NE 69339-0523 Ph: (308) 665-1546

News Archive

NOXXON Pharma completes first-in-human clinical trial with Spiegelmer NOX-A12

NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, announced today the successful completion of the first-in-human clinical trial with Spiegelmer® NOX-A12.

Chemoradiation improves survival rates among subset of elderly head and neck cancer patients

The addition of chemotherapy (CT) to radiation therapy (RT) improves survival rates among a subset of elderly head and neck cancer patients, specifically those ages 71 to 79 with low comorbidity scores and advanced disease stage, according to research presented at the 2016 Multidisciplinary Head and Neck Cancer Symposium.

Standardizable assay detects T cell responses to SARS-CoV-2 infection

Researchers in the UK have developed a high-throughput standardizable assay that accurately detects T cell responses to infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

Left handedness may be linked to an increased risk of breast cancer

Researchers in the Netherlands examined the relation between handedness and incidence of breast cancer in over 12,000 healthy, middle aged women born between 1932 and 1941.

Cardiac rehabilitation services insufficiently implemented, says York University professor

Rehabilitation programs must become an integral part of cardiac care to significantly reduce the burden of living with heart disease, one of the most common chronic diseases and causes of death globally, according to York University Professor Sherry Grace.

Dr Gay C Gilmore, MD - General Practice in Crawford, NE